MA42681B1 - Inhibiteurs de l'ezh2 - Google Patents

Inhibiteurs de l'ezh2

Info

Publication number
MA42681B1
MA42681B1 MA42681A MA42681A MA42681B1 MA 42681 B1 MA42681 B1 MA 42681B1 MA 42681 A MA42681 A MA 42681A MA 42681 A MA42681 A MA 42681A MA 42681 B1 MA42681 B1 MA 42681B1
Authority
MA
Morocco
Prior art keywords
compounds
ezh2 inhibitors
tumors
ezh2
enhancer
Prior art date
Application number
MA42681A
Other languages
English (en)
Inventor
Michael John Rodriguez
Esteban Dominguez
Deqi Guo
Mary Margaret Mader
Anh-Quan Hannah Nguyen
Prado Miriam Filadelfa Del
Michael Enrico Richett
Yvonne Yee Mai Yip
Kuo-Long Yu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2016/047989 external-priority patent/WO2017035060A1/fr
Publication of MA42681B1 publication Critical patent/MA42681B1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés qui inhibent l'activité de l'histone lysine n-méthyltransférase ezh2 (enhancer of zeste homolog 2), des compositions pharmaceutiques comprenant ces composés, et des méthodes d'utilisation de ces composés pour traiter le cancer, par exemple les tumeurs hématologiques et les tumeurs solides.
MA42681A 2015-08-27 2016-08-22 Inhibiteurs de l'ezh2 MA42681B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382433 2015-08-27
PCT/US2016/047989 WO2017035060A1 (fr) 2015-08-27 2016-08-22 Inhibiteurs de l'ezh2

Publications (1)

Publication Number Publication Date
MA42681B1 true MA42681B1 (fr) 2020-01-31

Family

ID=54145713

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42681A MA42681B1 (fr) 2015-08-27 2016-08-22 Inhibiteurs de l'ezh2

Country Status (2)

Country Link
AR (1) AR105666A1 (fr)
MA (1) MA42681B1 (fr)

Also Published As

Publication number Publication date
AR105666A1 (es) 2017-10-25

Similar Documents

Publication Publication Date Title
PH12019501396A1 (en) Compositions and methods for inhibiting arginase activity
MX2017012730A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido) para el tratamiento de cancer.
PH12015502028A1 (en) Ido inhibitors
MX2016000295A (es) Inhibidores de indoleamina 2,3-dioxigenasa (ido).
MX2016002075A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido).
EA201891057A1 (ru) Композиции и способы для ингибирования активности аргиназы
PH12016502179A1 (en) Inhibitors of lysine specific demethylase-1
EA201591599A1 (ru) Ингибиторы ido
PH12018500423A1 (en) Inhibitors of ezh2
MX2015017486A (es) Inhibidores de indolamina 2,3-dioxigenasa (dio).
MA47736B1 (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
MX2017015923A (es) Inhibidores de indolamina-2,3-dioxigenasa (ido).
MA42681B1 (fr) Inhibiteurs de l'ezh2
MA43158B1 (fr) Composés oxa-diazadispiro possédant une activité contre la douleur
EA202190125A1 (ru) ПРОИЗВОДНЫЕ ПИРИДОПИРИМИДИНОНА ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Axl
EA202191138A1 (ru) Композиции и способы для ингибирования активности аргиназы
EA202191495A1 (ru) Композиции и способы ингибирования активности аргиназы
EA201892527A1 (ru) Ингибиторы энхансера гомолога 2 белка zeste